The neuromodulation developer Saluda Medical announced that it raised $100 million to help bolster the sales of its ...

Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced its five-year growth ...

Earache in kids is common and can result from different causes. For example, your child may complain about pain in the ears ...

“Although we cannot claim that gabapentin does not lead to higher risk for falls at any time, our study does suggest that the ...

In a personal essay for PEOPLE, TikTok star Eldiara Doucette opens up about her recurring soft tissue cancer, losing her ...

As we observe Glaucoma Awareness Month this January, it is essential to recognize the significance of regular eye checkups, ...

A holistic approach to managing chronic pain focuses on addressing the root cause of discomfort rather than simply masking pain. Join the Peak's email list for the top headlines right in your inbox ...

A newly published study from Aarhus University Hospital shows that fecal microbiota transplantation (FMT)—a method where gut ...

Nalu Medical, Inc. ("Nalu"), a leader in peripheral nerve stimulation, announced the publication of a study in Pain Management journal showing that the use of Nalu PNS therapy in chronic pain patients ...

Pacira receives FDA approval for a new iovera Smart Tip aimed at expanding pain management capabilities to deeper nerves like ...

Pacira launches a new iovera° Smart Tip for chronic back pain relief, offering an alternative to radiofrequency ablation with ...

Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, announced today that it has received clearance ...